Safety Assessment of Newly Expressed Proteins in Genetically Modified Crops: A Decade of Regulatory Case Studies
Authors:
- Cunxi WangCWCunxi Wang
- Christopher R. BrownCBChristopher R. Brown
- Tommi A. WhiteTommi A. White
- Beverly F. AndersonBABeverly F. Anderson
- Yong YinYYYong Yin
- Harit K. BalHBHarit K. Bal
- Collin J. PreftakesCPCollin J. Preftakes
- Rong WangRWRong Wang
- Scott A. SaraccoSSScott A. Saracco
- Kimberly Hodge-BellKHKimberly Hodge-Bell
- Steven L. LevineSLSteven L. Levine
- David CaldwellDCDavid Caldwell
Open Access
Abstract
This review synthesizes regulatory and scientific evidence accumulated over the past decade supporting the safety of newly expressed proteins (NEPs) in genetically modified (GM) crops. Using five case studies representing diverse protein classes, including dicamba monooxygenase (DMO), protoporphyrinogen IX oxidase (PPO), Cry1B.2/Cry1B.3, Mpp75Aa1.1, and Vip3Cb1, it illustrates how science-based, case-by-case, weight-of-evidence approaches are applied in food and feed safety assessment and ecological risk assessment (ERA) for regulatory submissions. These examples demonstrate how hazard identification, hazard characterization, and exposure assessment are integrated across proteins with diverse biological functions, structural characteristics, and levels of familiarity. It further examines the safety relevance of protein processing and sequence variation arising from protein engineering or biological processing and discusses the scientific basis supporting bridging and read-across approaches, including phylogenetic relationships, sequence similarity, structural conservation, domain architecture, and functional equivalence. The increasing application of safe-by-design principles and bridging strategies is highlighted as an important advancement enabling efficient, scientifically robust evaluations while reducing unnecessary testing. The review also discusses the convergence of food/feed safety assessment and ERA and future directions. Overall, accumulated evidence from NEPs commercialized to date in GM crops has not identified hazards for the assessed safety endpoints and supports the continued evolution and modernization of protein safety assessment frameworks.Keywords
All Related Versions
This publication has 122 references indexed in Scilit:
- Benefits, concerns, and sustainable alternatives to genetically modified crops from a global and Indian perspectiveThe Plant Genome, 2025
- Meta‐analysis on effects of Bt‐maize on nontarget invertebrates – Data transportability across continentsPlants, People, Planet, 2025
- Genetically modified crops and sustainable development: navigating challenges and opportunitiesFood Science and Biotechnology, 2024
- Characterization of HemY-type protoporphyrinogen IX oxidase genes from cyanobacteria and their functioning in transgenic ArabidopsisPlant Molecular Biology, 2019
- Microbial HemG‐type protoporphyrinogen IX oxidase enzymes for biotechnology applications in plant herbicide tolerance traitsPest Management Science, 2019
- Improvements to the APBS biomolecular solvation software suiteProtein Science, 2017
- N‐Terminal Methionine ProcessingCurrent Protocols in Protein Science, 2017
- An Introduction to Sequence Similarity (“Homology”) SearchingCurrent Protocols in Bioinformatics, 2013
- Methods of Protein Structure Comparison2011
- Rapid comparison of properties on protein surfaceProteins: Structure, Function, and Bioinformatics, 2008